 |
17-allylamino-17-demethoxygeldanamycin (17-AGG) |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2004-09-03 00:00:00 |
| Sponsor | Bristol-Myers Squibb Company;Research & Development, 5 Research Parkway;Wallingford, Connecticut, 06492 |
Related Access Program
Pusan National University Hospital – Chronic Myeloid Leukemia
University of California, San Francisco – Chronic Myeloid Leukemia
Emory University – Chronic Myeloid Leukemia
Pusan National University Hospital – Chronic myeloid leukemia
University of California, San Francisco – Chronic myeloid leukemia
Pfizer – Chronic myeloid leukemia
Emory University – Chronic myeloid leukemia